10x Genomics, Inc. — Director's Dealing 2019

Oct 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2019-10-14

Reporting Person: Saxonov Serge (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-14	Class A Common Stock	M	4167	$1.07	Acquired	919352	Direct
2019-10-14	Class A Common Stock	M	6250	$1.20	Acquired	925602	Direct
2019-10-14	Class A Common Stock	M	4167	$1.20	Acquired	929769	Direct
2019-10-14	Class A Common Stock	M	5208	$5.04	Acquired	934977	Direct
2019-10-14	Class A Common Stock	M	3037	$11.48	Acquired	938014	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-14	Stock Option (right to buy)	$1.07	M	4167	Disposed	2026-11-18	Class A Common Stock (4167)	Direct
2019-10-14	Stock Option (right to buy)	$1.20	M	6250	Disposed	2027-10-18	Class A Common Stock (6250)	Direct
2019-10-14	Stock Option (right to buy)	$1.20	M	4167	Disposed	2027-10-18	Class A Common Stock (4167)	Direct
2019-10-14	Stock Option (right to buy)	$5.04	M	5208	Disposed	2028-11-02	Class A Common Stock (5208)	Direct
2019-10-14	Stock Option (right to buy)	$11.48	M	3037	Disposed	2029-05-10	Class A Common Stock (3037)	Direct

Footnotes

F1: This option, originally for 200,000 shares, of which 158,333 have been exercised, vested as to one-fourth of the shares on August 1, 2017, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F2: This option, originally for 300,000 shares, of which 156,250 have been exercised, vested as to one forty-eighth of the shares on October 1, 2017, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F3: This option, originally for 150,000 shares, of which 37,500 have been exercised, vested as to one thirty-sixth of the shares on January 1, 2019, and one thirty-sixth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date

F4: This option, originally for 250,000 shares, of which 67,708 have been exercised, vested as to one forty-eighth of the shares on October 1, 2018, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F5: This option, originally for 145,786 shares, of which 18,223 have been exercised, vested as to one forty-eighth of the shares on May 1, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.